Akshay Vaishnaw - Jun 18, 2021 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
President, R&D
Signature
By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Akshay K. Vaishnaw
Stock symbol
ALNY
Transactions as of
Jun 18, 2021
Transactions value $
-$1,850,405
Form type
4
Date filed
6/22/2021, 04:07 PM
Previous filing
Jun 7, 2021
Next filing
Aug 11, 2021
SEC
View on sec.gov

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Performance Stock Option 2013 (right to buy) Options Exercise $0 -10.8K -33.34% $0.00 21.7K Jun 18, 2021 Common Stock 10.8K $63.00 Direct F1
transaction ALNY Stock Option (right to buy) Options Exercise $0 -970 -29.06% $0.00 2.37K Jun 18, 2021 Common Stock 970 $42.22 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2021.
F2 Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
F3 The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.